Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market To Worth Over US$ 29,365.3 Million with 7.1% CAGR up to 2027

Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market – Insights

Attention deficit hyperactivity disorder (ADHD) is a neurological condition that leads to impulsive and hyperactive behaviors in patients along with difficulty in maintaining attentiveness. Counseling, medications, and chance in lifestyle can collectively aid in reducing the symptoms of the disease and improve the quality of life in patients. The condition is commonly evident in adults and children. The root cause of ADHD remains unknown is several cases. According to the National Institute of Mental Health (NIMH), heredity factors, brain injuries, low birth weight, use of drugs during pregnancy, or exposure to environmental toxins such as lead in early age may lead to neurological disorders.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/830

Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market: Drivers

Increasing prevalence of ADHD is a major factor boosting growth of the attention-deficit/hyperactivity disorder treatment market. For instance, according to the National Institute of Health, 2015, the prevalence of ADHD is higher by 30% in boys, with 5.1 million children being diagnosed with ADHD, globally in 2013 and the number expected to rise to 18 million by 2020.

Moreover, the awareness regarding ADHD symptoms is increasing among patients and physicians and opinion-based diagnosis is highly adopted due to absence of standard diagnostic tests, which is also expected to boost growth of the market over the forecast period. Increasing use of additives and preservatives in diet, value systems impacting quality of births, and changing lifestyles may increase the risk of ADHD, which is also contributing to growth of the market.

Quick Buy – Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/830

Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market: Restraints

Low availability of non-stimulants ADHD drugs may hinder growth of the market. Moreover, existence of multiple conditions such as schizophrenia or depression in children may pose challenge in diagnosis of ADHD in emerging regions of Middle East and Africa. This in turn may also hamper the market growth.

Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market: Taxonomy

Among drug types, the non-stimulants segment is expected to hold dominant position in the global attention-deficit/hyperactivity disorder treatment market over the forecast period. This is attributed to the ability of non-stimulants to enhance focus and impulsivity.

The global attention deficit hyperactivity disorder treatment market is segmented on the basis of drug type, therapy, distribution channel, and region.

By Drug Type:

• Stimulants
  • Amphetamine
  • Methylphenidate
  • Dexmethylphenidate
  • Dextroamphetamine
  • Lisdexamfetamine Dimesylate
• Non-stimulants
  • Atomoxetine
  • Clonidine
  • Guanfacine
  • Bupropion

By Therapy:

• Behavior Therapy
• Cognitive Behavioral Therapy
• Interpersonal Psychotherapy
• Family Therapy

By Distribution Channel:

• Specialty Clinics
• Retail Pharmacies
• Hospital Pharmacies
• e-Commerce

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/attention-deficit-hyperactivity-disorder-therapeutics-market-3368

Attention-deficit/Hyperactivity Disorder (ADHD) Treatment Market: Regional Analysis  

North America is expected to account for the largest share in the global attention-deficit/hyperactivity disorder treatment market over the forecast period. This is attributed to factors such as increasing clinical trials related to ADHD therapies, rapid U.S. FDA approval of therapeutics, developments in brain monitoring technologies, favorable insurance policies and government support, and increasing prevalence of ADHD in the region. For instance, according to the Centers for Disease Control and Prevention (CDC) 2014, around 6.4 million children in the U.S. between the ages 4-17 are diagnosed with ADHD. Increasing health awareness and manufacturing of effective ADHD therapies is expected to boost growth of the market in Asia Pacific.

Table of Content

Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Research Report
Section 1: Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Industry Overview
Section 2: Global Economic Impact on Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Forecast

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837